Navigation Links
Certifications, Presentation of Study Results and Earnings Releases - Research Report on Agilent, Mindray, Bard, Tornier, and Life Technologies
Date:11/11/2013

2 Co-Primary Investigator, presented data related to the study design, demographics, and six-month follow-up results from the patients randomized in the LEVANT 2 Lutonix Drug-Coated Balloon (DCB) trial, at the Transcatheter Cardiovascular Therapies (TCT) conference in San Francisco, California. The Company informed that the follow-up results from randomized patients, treated with the Lutonix DCB demonstrated safety comparable to uncoated balloons (94.0% vs 94.1%) and superior primary patency (92.3% vs 82.7%, p=0.003) by Kaplan-Meier time-to-event analysis. According to Bard, interested parties may access the presentation slides at the Company website, which will be available for a limited time period. The Full Research Report on C.R. Bard, Inc - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

[http://www.analystscorner.com/r/full_research_report/141e_BCR]

--

Tornier N.V. Research Report

On November 5, 2013, Tornier N.V. (Tornier) released its Q3 FY 2013 financial results (period ended September 29, 2013) with revenues of $66.7 million, up 15.1% YoY. Q3 FY 2013 revenue of the Company's extremities product categories totaled $56.9 million, compared to $48.7 million in Q3 FY 2012. Tornier also reported that non-GAAP gross margins improved to 74.2% in Q3 FY 2013 from 73.4% in Q3 FY 2012. Dave Mowry, President and CEO of Tornier, said, "We delivered adjusted EBITDA within our guidance range despite the lower than expected revenue. This was driven by an improvement in non-GAAP gross margin and prudent management of operating expenses. We believe we have the infrastructure in place to support our double-digit constant currency revenue growth and enhanced operating leverage expectations." Tornier stated that for Q4 FY 2013 it expects constant currency
'/>"/>

SOURCE Analysts' Corner
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. HeartWare Presentation At The Canaccord Genuity Medical Technology & Diagnostics Forum To Be Webcast
2. ViroPharma Announces Upcoming Data Presentations at the 2013 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting
3. Hologic to Host Investor Presentation at RSNA 2013
4. Thoratec Announces Presentations At Investor Conferences For November 2013
5. Orexigen Therapeutics Announces Date of Third Quarter 2013 Financial Results Conference Call and Upcoming Presentation at Credit Suisse Healthcare Conference
6. Vital Access Reports Live VWING Clinical Cases and SAVE Study Clinical Data Presentation at CiDA Conference
7. Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013
8. Volcano Announces Upcoming Data Presentations from Large-Scale Studies on Physiology and Imaging Technologies at TCT 2013
9. Healthcare Sector Announced Clinical Data Presentation, Upcoming Financial Release Schedules and Updates on New Drug Applications - Research Report on Alexion, Pacira, pSivida, Momenta and Impax
10. Medac Pharma, Inc. Announces Multiple Poster Presentations During the 2013 ACR/ARHP Annual Meeting
11. Diabetes Alliance to Feature 17 Presentations for Linagliptin and Investigational Compound Empagliflozin^ During the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... July 21, 2014 Galmed Pharmaceuticals Ltd. (Nasdaq: ... focused on the development and commercialization of a once-daily, ... cholesterol gallstones, announced today that it will host a ... to discuss results for the period ended June 30, ... with respect to its clinical program for aramchol. ...
(Date:7/21/2014)... Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... treatments for cancer and its associated pain, today announced ... development of a small molecule inhibitor targeting the important ... protein has also been recognized as an important determinant ... as a dominant factor in most human cancers and ...
(Date:7/21/2014)... MARYVILLE, Ill. , July 21, 2014 /PRNewswire-iReach/ ... that Dr. Ryan Diederich has been ... on Membership and Advocacy for 2014-2015. This council ... member resources, services and benefits. The ... that represents and unifies its physician members as ...
Breaking Medicine Technology:Galmed Pharmaceuticals Second Quarter 2014 Conference Call and Webcast Scheduled for Friday, July 25, 2014 2Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 2Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 3Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 4
... Dec. 21, 2011  VIVUS, Inc. (NASDAQ: VVUS ... retrospective study of medical claims data on oral ... utero .  The study, known as FORTRESS for ... mother-infant dyads exposed to topiramate either alone (monotherapy) ...
... Dec. 21, 2011 Despite the numerous medical advances ... the United States is still higher than most European ... the growing rate of pre-term births, researchers are committed ... Northwestern Medicine ® researchers are examining ...
Cached Medicine Technology:VIVUS Reports Topline Findings From FORTRESS 2VIVUS Reports Topline Findings From FORTRESS 3VIVUS Reports Topline Findings From FORTRESS 4VIVUS Reports Topline Findings From FORTRESS 5VIVUS Reports Topline Findings From FORTRESS 6Northwestern Researchers Trial New Device that May Support Improved Newborn Health 2Northwestern Researchers Trial New Device that May Support Improved Newborn Health 3Northwestern Researchers Trial New Device that May Support Improved Newborn Health 4
(Date:7/22/2014)... 2014 A new and technologically unique ... with results that are surprising even the most skeptical ... skin with radio frequency, ThermiTight has been dubbed “InjectableRF” ... the skin to “inject” heat to the tissues which ... single treatment solution for skin laxity produces results in ...
(Date:7/21/2014)... On Monday, September 22, 2014 Push to Walk will ... Solutions at The Knoll West Country Club, Knoll & Greenbank ... at 11 a.m. The price of $225 includes all ... $250 after September 7th. Non-golfers and guests are welcome ... dinner will include a special silent and live auction in ...
(Date:7/21/2014)... PowerObjects, a professional services firm ... add-ons for Microsoft Dynamics CRM, has joined the ... group of the most strategic Microsoft Dynamics partners ... rank them in the highest echelon of the ... the Microsoft Dynamics Inner Circle have performed to ...
(Date:7/21/2014)... It,s human nature to hate losing. , Unfortunately, ... potentially abandoning a solid strategy and thus increasing your ... one conclusion of a Brigham Young University study published ... The finding is based on an analysis of two ... researchers focused on whether coaches adjusted their personnel following ...
(Date:7/21/2014)... Center for Public Affairs Research has released the results ... what it means to be a quality health care ... the Robert Wood Johnson Foundation, sheds new light on ... care and doctors, as well as the information they ... survey produces new and actionable data during a crucial ...
Breaking Medicine News(10 mins):Health News:New Minimally Invasive Procedure, ThermiTight, “Injects” Radio Frequency to Treat Skin Laxity 2Health News:7th Annual Push to Walk Golf Outing to Be Held September 22nd 2Health News:PowerObjects Joins the 2014 Microsoft Dynamics Inner Circle 2Health News:'Moral victories' might spare you from losing again 2Health News:National survey from AP-NORC examines perceptions of health care provider quality 2
... of therapeutic agents that interferes with the ability of ... The results of the new study will be presented ... Meeting in San Francisco. , The cell-based study ... compounds are likely to be effective against breast cancers ...
... scientists work collaboratively, barriers of religion and ethnicity ... science to improve the lives of citizens worldwide. ... Gluck, professor of neuroscience at Rutgers University in ... after successfully organizing an international conference co-hosted by ...
... 16 Pittsburgh-based Foundation,Radiology Group (FRG) and Cherry ... which will make FRG the exclusive provider of,diagnostic ... Kishor E. Joshi, M.D., president of Cherry Tree ... Foundation Radiology Group. We expect,this partnership will enhance ...
... Association, a,regional non-profit established to foster relationships and ... announced today,the election of five new officers and ... New officers who were elected to serve a ... president, Aon Consulting; Past President - Thomas,Hoffman, partner, ...
... studies indicate that oral use of RU-486,s companion drug misoprostol ... , The off-label use of a drug given with RU-486 ... of rare, fatal infections seen in women taking the drugs ... , The drug misoprostol is FDA-approved to be taken ...
... & Lymphoma Society,s Light The Night(R) Walk Offers Relief at ... the ... prices may be,putting the brakes on Americans, summer travel plans, but The ... cards,and a chance to win an all-expense paid vacation., Light The ...
Cached Medicine News:Health News:Future hope for patients with breast cancers resistant to tamoxifen 2Health News:US-Israeli-Palestinian collaboration to advance Alzheimer's disease research 2Health News:Foundation Radiology Group and Cherry Tree Medical Associates Sign Multi-Year Contract for Diagnostic Services 2Health News:SouthWest Benefits Association Elects New Board of Directors 2Health News:Abortion drug's off-label use may have led to deaths 2Health News:Abortion drug's off-label use may have led to deaths 3Health News:Get Free Gas and Help Save a Life 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: